Skip to content
RECEIVE FREE EXPRESS SHIPPING ON ALL ORDERS OVER $150 DELIVERED IN AUSTRALIA
RECEIVE FREE EXPRESS SHIPPING ON ALL ORDERS OVER $150 DELIVERED IN AUSTRALIA

PainX Raspberry flavour 120 g oral powder

PainX Raspberry flavour 120 g oral powder is a Practitioner-Grade product available for customers under the care of a practitioner.

Practitioner Products

To purchase any Practitioner Grade products you must have have a patient account with Health Freek.

Apply For An Account
or
Login to your Account
  • Reduces and relieves nerve pain and persistent muscular pain, cramps, and spasm.
  • For neuromuscular pain, such as shoulder and back pain, head and neck pain, sciatic pain, and fibromyalgia pain.
  • PEA is analgesic and anti-inflammatory, exerts endocannabinoid activity and reduces pain amplification and muscle pain.
  • Contains highly bioavailable PEA and exclusive Meta Mag® Magnesium.
Clinical Benefits

Relieves neuromuscular pain: Magnesium exerts muscle-relaxing actions (and prevents muscle spasms) via multiple mechanisms and is a natural glutamate antagonist.1 Glutamate is involved in central sensitisation and pain amplification.2 Magnesium regulates neuromuscular transmission by blocking the entry of calcium ions in synaptic nerve terminals,3 as well as inhibiting presynaptic acetylcholine release, which propagates impulses between motor nerves and muscles.4

Higher magnesium intake has found to be protective against chronicpain.5 However, one third of Australian adults fail to meet their requirementsfor adequate magnesium intake.6 PainX contains 420 mg/d to support adultsto meet the recommended intake of 310 to 320 mg/d in women and 400 to420 mg/d in men.7

Figure 1: Magnesium and PEA Address Multiple Drivers of Pain Amplification

Palmitoylethanolamide (PEA) promotes endogenous cannabinoidsystem (ECS) activity through its ability to augment the activity ofcannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).8These receptors are expressed in nerve tissue and immune cells and areinvolved in modulating the inflammatory response by suppressing immunecell activation, which can reduce pain perception.9 PEA proves to be effectiveand safe in nerve compression syndromes. In one pivotal, double blind,placebo-controlled trial in 636 sciatic pain patients, subjective pain scoreswere reduced from 6.5/10 to 3.6/10 in the 300 mg/d group, while in the 600mg/d group scores were reduced from 7.1/10 to 2.1/10 compared to placebo,which decreased from 6.6/10 to 4.6 (Figure 2).10

Figure 2: Outcomes of 600 mg/d of PEA on Sciatic Pain.

Meta Mag® and Levagen+™ are both exclusive types of magnesiumand PEA, respectively, that show enhanced bioavailability.11 Meta Mag®is different to magnesium salts and other magnesium chelates becauseit is covalently bound to two glycine molecules.12 Levagen+™ is a highlybioavailable PEA using LipiSperse® technology for enhanced absorption.13The Levagen+™ absorption studies show that Levagen+™ is 1.7 times betterabsorbed and that it stays in the plasma for a longer period of time comparedto a standard PEA (Levagen®) (Figure 3). Clinically, 600 mg/d of Levagen+™PEA is likely to equate to consuming 1,000 mg/d of a standard micronised PEA(Levagen®). A Practitioner can expect Levagen+™ to produce greater efficacyand to last longer in the body.14

Figure 3: Levagen+™ PEA vs Standard PEA

PainX contains 750 mg of malic acid per dose.

Levagen+™ is owned by Gencor Pacific Limited.Meta Mag® is a registered trademark of Balchem Corp.

Directions
Directions

Adults: Add 1 scoop (5 g) to 200 mL water twice daily.

This product is naturally coloured with a black carrot extract which interacts when mixed in waterto cause a colour change. As the product is stirred into water, it will turn blue before returning toa dark red hue.